Enovis Corporation (ENOV) financial statements and ratios from SEC XBRL: revenue $2.25B (TTM), net margin -52.7%, revenue growth 6.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.25B |
| Net Margin | -52.7% |
| Revenue Growth (YoY) | 6.7% |
| EPS Growth (YoY) | 39.0% |
| FCF Growth (YoY) | -129.6% |
| Price / Book | 1.02 |
| Price / Sales | 0.65 |
| FCF Yield | -4.5% |
| Altman Z-Score | -0.34 (distress) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.6 |
ENOV overview · ENOV earnings · ENOV KPIs · ENOV investor relations · ENOV ownership · ENOV peers · ENOV filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.